Degeneration of the dendritic arbor as an index of neurotoxicity in identified catecholamine neurons in rat brain slices

Experimental Neurology

Volumn 151, Issue 2, 1998, Pages 221-228

  Johnson, Stephen M ^a   Bywood, Petra T ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

Brain slice; Catecholamine; Kainic acid; Neurodegeneration; Neurotoxic; Substantia nigra

Indexed keywords

DIAMINOBENZIDINE; KAINIC ACID; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CATECHOLAMINE NERVE CELL; CONTROLLED STUDY; DENDRITE; IMMUNOHISTOCHEMISTRY; MALE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TOPOGRAPHY;

EID: 0032103906     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6782     Document Type: Article

References (40)

1. Agid Y., Ruberg M., Javoy-Agid F., Hirsch E., Raisman-Vozari R., Vyas S., Faucheux B., Michel P., Kastner A., Blanchard V., Damier P., Villares J., Zhang P. Are dopaminergic neurons selectively vulnerable to Parkinson's disease. Adv. Neurol. 60:1993;148-164.
2. Aitken P. G., Breese G. R., Dudek F. F., Edwards F., Espanol M. T., Larkman P. M., Lipton P., Newman G. C., Nowak Jr T. S., Panizzon K. L. Preparative methods for brain slices: A discussion. J. Neurosci. Methods. 59:1995;139-149.
3. Andreeva N., Ungethum U., Heldt J., Marschhausen G., Altman T., Andersson K., Gross J. Elevated potassium enhances glutamate vulnerability of dopaminergic neurons developing in mesencephalic cell cultures. Exp. Neurol. 137:1996;255-262.
4. Beal M. F. Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 6:1992;3338-3344.
5. Carlsson M., Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinson's disease. Trends. Neurosci. 13:1990;272-276.
6. Casper D., Blum M. Epidermal growth factor and basic fibroblast growth factor protect dopaminergic neurons from glutamate toxicity in culture. J. Neurochem. 65:1995;1016-1026.
7. Chan-Palay V., Asan E. Alterations in catecholamine neurons of the Locus Coeruleus in Senile Dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J. Comp. Neurol. 287:1989;373-392.
8. Choi D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
9. Coyle J. T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
10. Doble A. Excitatory amino acid receptors and neurodegeneration. Therapie. 50:1995;319-337.
11. Edwards F. A., Konnerth A. Patch-clamping cells in sliced tissue preparations. Methods Enzymol. 207:1992;208-222.
12. Feig S., Lipton P. ND. J. Neurochem. 55:1990;473-483.
13. Freese A., Difiglia M., Koroshetz W. J., Beal M. F., Martin J. B. Characterization and mechanism of glutamate neurotoxicity in primary striatal cultures. Brain Res. 521:1990;254-256.
14. Garthwaite G., Garthwaite J. Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: Dependence on calcium concentration. Neurosci. Lett. 66:1986;193-198.
15. Garthwaite G., Garthwaite J. Neurotoxicity of excitatory amino acid receptor agonists in young rat hippocampal slices. J. Neurosci. Methods. 29:1989;33-42.
16. German D. C., Manaye K. F., Sonsalla P. K., Brooks B. A. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced Parkinsonism: Sparing of Calbindin-D28k-containing cells. Ann. N.Y. Acad. Sci. 648:1992;42-62.
17. Grisham J. W., Smith G. J. Predictive and mechanistic evaluation of toxic responses in mammalian cell culture systems. Pharmacol. Rev. 36:1984;151s-171s.
18. Hornykiewicz O., Kish S. J. Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45:1986;19-34.
19. Johnson S. M., Luo X. G., Bywood P. T. Neurotoxic effects of kainic acid on substantia nigra neurons in rat brain slices. Exp. Neurol. 1997.
20. Johnson S. M., Trussell D. C., McRitchie D. A., Halliday G. M., Hardman C. D. Anatomical and immunohistochemical identification of catecholaminergic neurones in brain slice preparations used in electrophysiology. J. Neurosci. Methods. 64:1996;83-93.
21. Kikuchi S., Kim S. U. Glutamate neurotoxicity in mesencephalic dopaminergic neurons in culture. J. Neurosci. 36:1993;558-569.
22. Kitigawa K., Matsumoto M., Niinobe M., Mihoshiba K., Hata R., Ueda H., Handa N., Fukunaga R., Isaka Y., Kimura K., Kamada T. Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage - Immunohistochemical investigation of dendritic damage. Neuroscience. 31:1989;401-411.
23. Lees G. J. Contributary mechanisms in the causation of neurodegenerative disorders. Neuroscience. 54:1993;287-322.
24. Lehman A. Pharmacological protection against the toxicity ofND. Neuropharmacology. 26:1987;1751-1761.
25. Lipton S. A., Rosenberg P. A. Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330:1994;613-622.
26. Mattson M. P., Kater S. B. Development and selective neurodegeneration in cell cultures from different hippocampal regions. Brain Res. 490:1989;110-125.
27. Mattson M. P., Rychlik B., You J. S., Sisken J. E. Sensitivity of cultured embryonic cerebral cortical neurons toexcitatory amino acid-induced calcium influx and neurotoxicity. Brain Res. 542:1991;97-106.
28. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:1990;379-387.
29. Newman G. C., Qi H., Hospod F. E., Grundmann K. Preservation of hippocampal brain slices within vivoin vitro. Brain Res. 575:1992;159-163.
30. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, San Diego.
31. Regan R. F., Choi D. W. The effect of NMDA, AMPA/kainate, and calcium channel antagonists on traumatic cortical neuronal injury in culture. Brain Res. 633:1994;236-242.
32. Rice M. E., Perez-Pinzon M. A., Lee E. J. K. Ascorbic acid, but not glutathione, is taken up by brain slices and preserves cell morphology. J. Neurophys. 71:1994;1591-1596.
33. Rothman S. M., Olney J. W. Glutamate and the pathophysiology of hypoxic-ischaemic brain damage. Ann. Neurol. 19:1987;105-111.
34. Sawada H., Kawamura T., Shimohama S., Akaike A., Kimura J. Different mechanisms of glutamate-induced neuronal death between dopaminergic and non-dopaminergic neurons in rat mesencephalic culture. J. Neurosci. Res. 43:1996;503-510.
35. Schurr A., Payne R. S., Heine M. F., Rigor B. M. Hypoxia, excitotoxicity, and neuroprotection in the hippocampal slice preparation. J. Neurosci. Methods. 59:1995;129-138.
36. Seniuk N. A., Tatton W. G., Greenwood C. E. Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP. Brain Res. 527:1990;7-20.
37. Weiss J. H., Choi D. W. Differential vulnerability to excitatory amino acid-induced toxicity and selective neuronal loss in neurodegenerative diseases. Can. J. Neurol. Sci. 18:1991;394-397.
38. Whittingham T. S. Metabolic studies in the hippocampal slice preparation. Brain Slices: Fundamentals, Applications and Implications. 1986;Karger, Basel. p. 59-69.
39. Williams J. T., Bobker D. H., Harris G. C. Synaptic potentials in locus coeruleus neurons in brain slices. Progress Brain Res. 88:1991;167-172.
40. Yamada T., McGeer P. L., Baimbridge K. G., McGeer E. G. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28k. Brain Res. 526:1990;303-307.